Narayana Hrudayalaya Ltd. has informed the Exchange regarding the approval of the Unaudited Standalone and Consolidated Financial Results for the quarter and period ended December 31, 2025 at its Board meeting held on February 13, 2026.
NH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Smallcap 250 and 0.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Narayana Hrudayalaya reported Q3FY26 standalone revenue of ₹9,687.81M, up ~12% YoY, with EBITDA rising ~33% to ₹2,206.15M and EBITDA margin expanding from 18.11% to 21.14%. Standalone net profit dipped ~4% to ₹757.37M due to a ₹452.76M exceptional charge from the new Labour Codes. On a consolidated basis, revenue surged ~61% YoY to ₹21,511.70M, largely driven by the newly acquired Practice Plus Group UK (PPG UK, GBP 188.78M deal closed Nov 6, 2025). Consolidated net profit from continuing operations fell ~34% to ₹1,280.86M due to higher finance/depreciation costs from the UK acquisition and a ₹509.36M exceptional Labour Codes charge. The Board also approved key actions including the MMRHL merger scheme (shareholder/creditor approval received Jan 2026), the NHIC demerger scheme filed with NCLT, and incorporation of a new wholly-owned subsidiary for northern India expansion.
Strong operating performance with margin expansion was overshadowed by the Labour Codes one-time charge and integration costs from the large UK acquisition, leading to a YoY decline in reported profit despite top-line acceleration. Shareholders should watch for synergy realisation from PPG UK and progress on the MMRHL merger and NHIC demerger schemes in coming quarters.